Riskpilot← Back to searchSign inGet full accessWolfdoc AB
ABActiveOrg 5592009939Gullandersgatan 5 CGeneral medical practice activities · NACE 8621Est. 20190 employees
Revenue 2024
SEK 77K
EBITDA margin
82.8%
+279% vs 2023
Equity ratio
60.0%
Financial strength
Net profit 2024
SEK 65K
+287% vs 2023
| Revenue | SEK 77K | — |
| EBITDA | SEK 64K | +279% |
| Net profit | SEK 65K | +287% |
| Total assets | SEK 193K | +57% |
| Equity | SEK 116K | +125% |
| Employees | 0 | — |
Legal name
Wolfdoc AB
Org number
5592009939
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 april 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Läkarbemanning inom primärvård, sjukhusverksamhet, samt idrotts- och evenemangsmedicinska uppdrag, via fysiska besök eller via chat, telefon.
Address
Gullandersgatan 5 C
Email
niclaswarnolf@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 71 | 0 | 0 | 0 | 77 |
| Staff expenses | — | — | −0 | −0 | −0 |
| EBITDA | −97 | −20 | −54 | −35 | 64 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −97 | −20 | −54 | −35 | 64 |
| Net financials | −1 | — | 0 | 1 | 1 |
| Profit before tax | −98 | −20 | −53 | −35 | 65 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −98 | −20 | −53 | −35 | 65 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 197 | 144 | 182 | 123 | 193 |
| Equity | 59 | 40 | 36 | 52 | 116 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 137 | 105 | 145 | 71 | 77 |
| Total debt | 137 | 105 | 145 | 71 | 77 |
EBITDA margin
82.8%
This company
15.8%
Market median
+424% vs market
20202024
Equity ratio
60.0%
This company
38.2%
Market median
+57% vs market
20202024
Return on equity
55.6%
This company
18.4%
Market median
+202% vs market
20202024
Net profit margin
84.2%
This company
8.1%
Market median
+940% vs market
20202024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20202024
Debt / equity
0.67×
This company
0.62×
Market median
+8% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wolfdoc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Birgitta Warnolf | Deputy Board Member | 0 companies |
| Per Christian Warnolf | Deputy Board Member | 0 companies |
| Erik Niclas Warnolf | Board of Directors | 0 companies |